Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for Graft Failure in CABG Patients
NCT06802926Phase 4Active, not recruiting
- Sponsor
- Ruijin Hospital
- Start
- Dec 2025
- Primary completion
- Oct 2027
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of colchicine in Graft failure, sponsored by Ruijin Hospital. Started Dec 2025; status: active, not recruiting.
02
Drugs
colchicine
03
Conditions
Graft failure
Beyond the preview
Go deeper on NCT06802926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06802926.